These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8535304)

  • 1. Suppression of normal and neoplastic human T cells with unconjugated monoclonal antibodies in SCID mouse chimeras.
    Zengerle U; Hoffmann-Fezer G; Schuh R; Thierfelder S
    Bone Marrow Transplant; 1995 Sep; 16(3):337-41. PubMed ID: 8535304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human peripheral blood lymphocyte reconstituted severe combined immunodeficient (hu-PBL-SCID) mice. A model for human islet allograft rejection.
    Shiroki R; Poindexter NJ; Woodle ES; Hussain MS; Mohanakumar T; Scharp DW
    Transplantation; 1994 Jun; 57(11):1555-62. PubMed ID: 8009588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-CD45 and anti-CD52 (Campath) monoclonal antibodies effectively eliminate systematically disseminated human non-Hodgkin's lymphoma B cells in Scid mice.
    de Kroon JF; de Paus RA; Kluin-Nelemans HC; Kluin PM; van Bergen CA; Munro AJ; Hale G; Willemze R; Falkenburg JH
    Exp Hematol; 1996 Jul; 24(8):919-26. PubMed ID: 8690051
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency.
    Murphy WJ; Conlon KC; Sayers TJ; Wiltrout RH; Back TC; Ortaldo JR; Longo DL
    J Immunol; 1993 Apr; 150(8 Pt 1):3634-42. PubMed ID: 8468492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-human tumor effect and generation of human cytotoxic T cells in SCID mice given human peripheral blood lymphocytes by the in vivo transfer of the Interleukin-6 gene using adenovirus vector.
    Tanaka F; Abe M; Akiyoshi T; Nomura T; Sugimachi K; Kishimoto T; Suzuki T; Okada M
    Cancer Res; 1997 Apr; 57(7):1335-43. PubMed ID: 9102222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of natural killer cells on engraftment of human lymphoid cells and on metastasis of human T-lymphoblastoid leukemia cells in C57BL/6J-scid mice and in C57BL/6J-scid bg mice.
    Christianson SW; Greiner DL; Schweitzer IB; Gott B; Beamer GL; Schweitzer PA; Hesselton RM; Shultz LD
    Cell Immunol; 1996 Aug; 171(2):186-99. PubMed ID: 8806787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IL-2Ralpha-Directed monoclonal antibodies provide effective therapy in a murine model of adult T-cell leukemia by a mechanism other than blockade of IL-2/IL-2Ralpha interaction.
    Phillips KE; Herring B; Wilson LA; Rickford MS; Zhang M; Goldman CK; Tso JY; Waldmann TA
    Cancer Res; 2000 Dec; 60(24):6977-84. PubMed ID: 11156399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific immunosuppression of human anti-murine antibody responses in hu-PBL-SCID mice.
    Bitoh S; Lang GM; Kierek-Jaszczuk D; Fujimoto S; Sehon AH
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):134-43. PubMed ID: 8357957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of HPV16 positive cervical cancer model in the hu-PBL-SCID mouse and its immunological features].
    Liang ZX; Cheng Q; Chen HZ; Xie X; Ye DF
    Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1465-9. PubMed ID: 15500747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of human anti-mouse idiotypic antibody responses in hu-PBL-SCID mice.
    Bitoh S; Lang GM; Sehon AH
    Hum Antibodies Hybridomas; 1993 Jul; 4(3):144-51. PubMed ID: 8357958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts.
    Alegre ML; Peterson LJ; Jeyarajah DR; Weiser M; Bluestone JA; Thistlethwaite JR
    J Immunol; 1994 Sep; 153(6):2738-49. PubMed ID: 8077678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of immunomodulators in the hu-PBL-SCID mouse model.
    Mead JR; Burger RA; Morrey JD; Warren RP; Okleberry KM; Sidwell RW
    Biotechnol Ther; 1993; 4(1-2):133-43. PubMed ID: 8374509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Porcine cell microchimerism but lack of productive porcine endogenous retrovirus (PERV) infection in naive and humanized SCID-beige mice treated with porcine peripheral blood mononuclear cells.
    Kuddus RH; Metes DM; Nalesnik MA; Logar AJ; Rao AS; Fung JJ
    Transpl Immunol; 2004; 13(1):15-24. PubMed ID: 15203124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activating Fc receptors are required for antitumor efficacy of the antibodies directed toward CD25 in a murine model of adult t-cell leukemia.
    Zhang M; Zhang Z; Garmestani K; Goldman CK; Ravetch JV; Brechbiel MW; Carrasquillo JA; Waldmann TA
    Cancer Res; 2004 Aug; 64(16):5825-9. PubMed ID: 15313926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peritoneal sanctuary for human lymphopoiesis in SCID mice injected with human peripheral blood lymphocytes from Epstein-Barr virus-negative donors.
    Hoffmann-Fezer G; Kranz B; Gall C; Thierfelder S
    Eur J Immunol; 1992 Dec; 22(12):3161-6. PubMed ID: 1359971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deficient cytokine response of human allergen-specific T lymphocytes from humanized SCID mice and reconstitution by professional antigen-presenting cells.
    Jarman ER; Perschke K; Montermann E; Herz U; Renz H; Knop J; Reske-Kunz AB
    J Allergy Clin Immunol; 2000 May; 105(5):967-74. PubMed ID: 10808178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of Epstein-Barr virus-induced human B-cell lymphoma in severe combined immunodeficient mice treated with CD3xCD19 bispecific antibodies, CD28 monospecific antibodies, and autologous T cells.
    Bohlen H; Manzke O; Titzer S; Lorenzen J; Kube D; Engert A; Abken H; Wolf J; Diehl V; Tesch H
    Cancer Res; 1997 May; 57(9):1704-9. PubMed ID: 9135012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type I interferon is a powerful inhibitor of in vivo HIV-1 infection and preserves human CD4(+) T cells from virus-induced depletion in SCID mice transplanted with human cells.
    Lapenta C; Santini SM; Proietti E; Rizza P; Logozzi M; Spada M; Parlato S; Fais S; Pitha PM; Belardelli F
    Virology; 1999 Oct; 263(1):78-88. PubMed ID: 10544084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.